ÂÜÀòÂÒÂ×

Tom Laundon is an experienced professional in the fields of biotechnology and venture capital, currently serving as a member at Wolfpack Investor Network and as a board member at SonoVol, which specializes in Acoustic Angiography technology. Laundon is also a member of the Board of Directors for NC State Alumni Association and chairs the Caldwell Fellows Committee. In addition, Laundon navigates early-stage technology entrepreneurs at First Flight Venture Center and previously held board positions with NC Biosciences Organization and Issue Trak, Inc. Notably, Laundon served as CFO for multiple companies, including Innocrin Pharmaceuticals and G1 Therapeutics, managing financial operations and strategic planning. Laundon's educational background includes an MBA from Harvard Business School and a BSIE from North Carolina State University.